Our portfolio

Nano Hybrids

Nano Hybrids has developed a novel technology that enables the one-step synthesis of a broad range of inorganic/organic core/shell nanoparticles without the use of solvents and additives. This innovative approach enhances efficiency, sustainability, and product purity, making it a significant advancement in nanomaterials. Nano Hybrids is committed to advancing nanotechnology through sustainable and efficient solutions.

Industry: Biotechnology, Chemistry, Nanomaterials

Want to get in contact about Nano Hybrids?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Enhancing plant growth with solar-powered nanotechnology.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Developing stool-based colorectal cancer screening for early detection.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.
Enhancing plant growth with solar-powered nanotechnology.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
Developing stool-based colorectal cancer screening for early detection.

OpticsFoundry

Revolutionizing optical circuit manufacturing by offering robotically assembled and modular optical circuit boards that are easy to design, order, and deploy.